Drugs / Ketosteril
Trials 8
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT03077048 | Mar 2017 → Apr 2018 | chronic kidney disease | Fresenius Kabi | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT07699627 | Sep 2026 → Sep 2030 expected | — | Centre Hospitalier le Mans | Not yet recruiting | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT05030168 | Dec 2021 → Dec 2023 | impaired renal function disease | Chulalongkorn University | Unknown | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT07374042 | Jan 2026 → Jan 2030 expected | chronic kidney disease | University Hospital, Clermont-Ferrand | Recruiting | No outcome recorded |
| Phase 3 | NCT06329622 | May 2024 → Jun 2026 overdue | chronic kidney disease, muscular atrophy | Huashan Hospital | Recruiting | No outcome recorded |
| Phase 3 | NCT05716880 | Jan 2023 → Feb 2027 expected | nephrotic syndrome | Military Institute od Medicine National Research Institute | Recruiting | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT00364884 | Aug 2006 → Aug 2007 | chronic kidney disease | National Taiwan University Hospital | Unknown | No outcome recorded |
| Phase 4 | NCT00363987 | May 2006 → Dec 2008 | diabetic kidney disease | Fresenius Kabi | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ketosteril | “Group I patients will receive keto-/amino acid (Ketosteril) supplemented low protein diet during the active treatment period while Group II patients will receive...” NCT00364884 ↗7“Keto acid analog Ketosteril (1 tablet / 10 kg body weight)” NCT07374042 ↗ |